Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy, Safety and Pharmacokinetics of Ascending Dosages of Moxidectin Alone and in Comparison to Ivermectin Against Strongyloides Stercoralis in Adults: a Randomized Controlled Trial

NCT04056325 is registered in ClinicalTrials.gov with Jennifer Keiser as lead sponsor.

NCT NCT04056325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04056325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy, Safety and Pharmacokinetics of Ascending Dosages of Moxidectin Alone and in Comparison to Ivermectin Against Strongyloides Stercoralis in Adults: a Randomized Controlled Trial
Lead sponsor
Jennifer Keiser
Phase
Phase 2/3
Overall status
Completed
Start date
November 27, 2019
Completion date
April 30, 2021
Enrollment
617 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

strongyloides stercoralis infection